Cargando…

Induction by Interleukin‐15 of Human Killer Cell Activity against Lung Cancer Cell Lines and Its Regulatory Mechanisms

Interleukin (IL)‐15 is a novel cytokine with IL‐2‐like activity. In the present study, we examined IL‐15‐mediated induction of killer activity of peripheral blood mononuclear cells (MNC) against lung cancer cell lines, and the regulatory mechanisms of this induction by IL‐15. Cytotoxic activity was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeuchi, Eiji, Yanagawa, Hiroaki, Yano, Seiji, Haku, Takashi, Sone, Saburo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1996
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921031/ https://www.ncbi.nlm.nih.gov/pubmed/9045960 http://dx.doi.org/10.1111/j.1349-7006.1996.tb03140.x

Ejemplares similares

Induction Mechanism of Human Blood CD8(+) T Cell Proliferation and Cytotoxicity by Natural Killer Cell Stimulatory Factor (Interleukin‐12)
por: Nabioullin, Roustem, et al.
Publicado: (1994)

Human Alveolar Macrophages Augment Natural Killer Cell Stimulatory Factor (Interleukin‐12)‐inducible Killer Activity from Autologous Blood Lymphocytes
por: Haku, Takashi, et al.
Publicado: (1995)

Comparative analysis of interleukin 15 and interleukin 2 for induction of killer activity and of type 2 cytokine production by mononuclear cells from lung cancer patients.
por: Takeuchi, E., et al.
Publicado: (1998)

Serum levels of interleukin 6 in patients with lung cancer.
por: Yanagawa, H., et al.
Publicado: (1995)

Anti‐ganglioside GM(2) Monoclonal Antibody‐dependent Killing of Human Lung Cancer Cells by Lymphocytes and Monocytes
por: Hanibuchi, Masaki, et al.
Publicado: (1996)

Lymphokine‐activated Killer Induction and Its Regulation by Macrophages in Malignant Pleural Effusions
por: Yanagawa, Hiroaki, et al.
Publicado: (1989)

Interleukin‐2‐inducible Killer Activity and Its Regulation by Blood Monocytes from Autologous Lymphocytes of Lung Cancer Patients
por: Sone, Saburo, et al.
Publicado: (1991)

Enhancement of Therapeutic Effect of Interleukin‐2 on Spontaneous Pulmonary Metastases of Lewis Lung Carcinoma by Killer Helper Factor Associated with Increased Induction of Killer Activity
por: Fukuta, Katsuyuki, et al.
Publicado: (1989)

Inhibition by Fibrin Coagulation of Lung Cancer Cell Destruction by Human Interleukin‐2‐activated Killer Cells
por: Atagi, Shinji, et al.
Publicado: (1992)

Killing of Alveolar Macrophages and of Monocytes that Have Responded to Granulocyte‐Macrophage Colony‐stimulating Factor by Human Lymphokine‐activated Killer Cells
por: Sone, Saburo, et al.
Publicado: (1989)

Cyclosporin A Enhances Susceptibility of Multi‐drug Resistant Human Cancer Cells to Anti‐P‐glycoprotein Antibody‐dependent Cytotoxicity of Monocytes, but Not of Lymphocytes
por: Yano, Seiji, et al.
Publicado: (1994)

Transduction of the Macrophage Colony‐stimulating Factor Gene into Human Multidrug Resistant Cancer Cells: Enhanced Therapeutic Efficacy of Monoclonal Anti‐P‐glycoprotein Antibody in Nude Mice
por: Sone, Saburo, et al.
Publicado: (1996)

A New Quinoline Derivative MS‐209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P‐glycoprotein‐expressing Human Small Cell Lung Cancer Cells
por: Nokihara, Hiroshi, et al.
Publicado: (2001)

Combination Therapy with Antibody and Interleukin–2 Gene Transfer against Multidrug–resistant Cancer Cells
por: Shinohara, Tsutomu, et al.
Publicado: (1997)

The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.
por: Kogure, Toshiaki, et al.
Publicado: (2002)

Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells
Publicado: (1996)

Reemerging Murine Typhus, Japan
por: Sakaguchi, Satoshi, et al.
Publicado: (2004)

Phenotypic and functional characterization of natural killer cells in rheumatoid arthritis-regulation with interleukin-15
por: Lin, Syh-Jae, et al.
Publicado: (2020)

Oligonucleotide Sequences Required for Natural Killer Cell Activation
por: Kuramoto, Etsuro, et al.
Publicado: (1992)

Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15
por: Lin, Syh-Jae, et al.
Publicado: (2019)

Suppression by Interleukin 4 of Activation of Human Blood Monocytes to the Tumoricidal State
por: Nishioka, Yasuhiko, et al.
Publicado: (1990)

Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells
por: Van Audenaerde, Jonas R.M., et al.
Publicado: (2017)

Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
por: Kennedy, Mary K., et al.
Publicado: (2000)

Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15
por: Lin, Syh-Jae, et al.
Publicado: (2017)

Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity
por: Van den Bergh, Johan, et al.
Publicado: (2015)

Enhancement by Monocytes of Perform Production and Its Gene Expression by Human CD8+ T Cells Stimulated with Interleukin‐2
por: Sugihara, Kohji, et al.
Publicado: (1992)

Interleukin (IL)-15Rα–deficient Natural Killer Cells Survive in Normal but Not IL-15Rα–deficient Mice
por: Koka, Rima, et al.
Publicado: (2003)

Interleukin-15 Signaling in HIF-1α Regulation in Natural Killer Cells, Insights Through Mathematical Models
por: Coulibaly, Anna, et al.
Publicado: (2019)

An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC
por: Fousek, Kristen, et al.
Publicado: (2023)

Granulocyte‐Macrophage Colony‐stimulating Factor Augments Lymphokine‐activated Killer Activity from Pleural Cavity Mononuclear Cells of Lung Cancer Patients without Malignant Effusion
por: Takahashi, Keiji, et al.
Publicado: (1995)

Synergy of Nocardia rubra Cell Wall Skeleton and Interleukin 2 in the in vivo Induction of Murine Lymphokine‐activated Killer Cell Activity
por: Kawase, Ichiro, et al.
Publicado: (1989)

Effect of binding immunoglobulin protein on induction of regulatory B cells with killer phenotype during inflammation and disease
por: Motaung, Bongani, et al.
Publicado: (2019)

Coordinate Expression and Trans Presentation of Interleukin (IL)-15Rα and IL-15 Supports Natural Killer Cell and Memory CD8(+) T Cell Homeostasis
por: Burkett, Patrick R., et al.
Publicado: (2004)

Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus
por: Lin, Syh-Jae, et al.
Publicado: (2016)

Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo
Publicado: (1990)

Bovine neonate natural killer cells are fully functional and highly responsive to interleukin-15 and to NKp46 receptor stimulation
por: Elhmouzi-Younes, Jamila, et al.
Publicado: (2009)

Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells
por: Terrén, Iñigo, et al.
Publicado: (2018)

Interleukin-15 suppresses gastric cancer liver metastases by enhancing natural killer cell activity in a murine model
por: Wang, Wei, et al.
Publicado: (2018)

Regulatory role of natural killer T cells in diabetes
por: Tard, Celine, et al.
Publicado: (2015)

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_sp4enfpi0npr01a9i1p2q92kdu